Nexus among health expenditures, ICTs and sustainable economic growth: Insights from South Asian Nationals health and economic issues [0.03%]
医疗卫生支出、信息通信技术与可持续经济增长之间的关系：来自南亚国家的启示
Linmin Chen,Aysha Zamir,Malik Shahzad Shabbir et al.
Linmin Chen et al.
This study aims to inspect the relationship between environmental degradation, health expenditure, energy market, ICT, and sustainable economic growth in a dynamic framework using Panel VAR and GMM approaches. This investigation adopted a b...
Marina Cavalieri,Stefania Fontana,Calogero Guccio et al.
Marina Cavalieri et al.
The recent Covid-19 pandemic has shown how even high-performing healthcare systems are often unprepared to cope with sudden and unforeseen surges in demand for healthcare services, drawing further attention on crucial factors ensuring their...
Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland [0.03%]
英格兰和苏格兰的长新冠相关健康经济结果和国家经济影响
Joseph Kwon,Joseph Mensah,Ruairidh Milne et al.
Joseph Kwon et al.
Background: Two million people in the UK suffer from Long COVID (LC), imposing substantial health economic impacts. This study aimed to: 1) assess longitudinal changes in health utility scores and economic costs of LC, an...
Pharmacy cost groups for the German morbidity-based risk compensation scheme [0.03%]
基于德国疾病风险补偿计划的药房成本组
Christian J A Schindler,Benjamin Berndt,Dennis Häckl
Christian J A Schindler
Introduction: To ensure fair competition and prevent risk selection by sickness funds, Germany employs a morbidity-based risk-adjustment scheme, primarily using diagnostic data to record insured persons' morbidity. Howeve...
A model-based cost-effectiveness analysis of prescribing by dietitians and therapeutic radiographers in England [0.03%]
基于模型的成本效益分析：英格兰营养师和放射治疗师的处方开药情况
Saeideh Babashahi,Nicola Carey,Karen Stenner et al.
Saeideh Babashahi et al.
Trends in physical and mental health needs across generations in Australia [0.03%]
澳大利亚几代人身体和心理健康需求的变化趋势
Sabrina Lenzen,Luke Connelly,William Whittaker et al.
Sabrina Lenzen et al.
Despite evidence of changes in age-specific incidence and prevalence rates for chronic conditions and disease, future health resource planning is often based on historical age- and gender-specific service use, neglecting changes in the need...
Cost-effectiveness of treatments for presymptomatic newborn patients with spinal muscular atrophy and two or three copies of the survival motor neuron 2 gene in Italy [0.03%]
意大利两型和三型生存 Motor 神经元基因无症状新生儿脊髓性肌萎缩症患者治疗的成本效益分析
Ilaria Valentini,Gianni Ghetti,Marika Pane et al.
Ilaria Valentini et al.
Objective: We assessed the cost effectiveness of onasemnogene abeparvovec (OA) for presymptomatic infants with two or three copies of the survival motor neuron 2 (SMN2) gene (diagnosed/treated ≤ 6 weeks old) who lack fun...
Cost-effectiveness of Mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy using a French healthcare perspective [0.03%]
从法国卫生保健角度评估莫西卡亭治疗症状性梗阻性肥厚型心肌病患者的成本效益
Francois-Emery Cotté,Michael Hurst,Sarah Akarkoub et al.
Francois-Emery Cotté et al.
Arthur E Attema,Marcello Antonini,Mesfin Genie et al.
Arthur E Attema et al.
Clinical equivalence and non-inferiority within health technology assessment [0.03%]
卫生技术评估中的临床等效性和非劣效性
Matthew Taylor,Joe Goldbacher,Charlotte Graham et al.
Matthew Taylor et al.
Background: Non-inferiority and clinical equivalence clinical trials can be used to determine whether a health technology is no worse than an existing treatment. This study identified international guidance for conducting...